Skip to content
XPR – Lifestyle Demo
Author:
Dualitas Therapeutics
Dualitas Therapeutics Appoints Karim Dabbagh as Chief Executive Officer to Advance Novel Bispecific Antibody Pipeline Toward the Clinic
June 8, 2026